The antinociceptive effect of artemisinin on the inflammatorypain and role of GABAergic and opioidergic systems
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background: Pain is a complex mechanism which involves different systems, including the opioidergic and GABAergic systems. Due to the side effects of chemical analgesic agents, attention toward natural agents have been increased. Artemisinin is an herbal compound with widespread modern and traditional therapeutic indications, which its interaction with the GABAergic system and antinoniceptive effects on neuropathic pain have shown. Therefore, this study was designed to evaluate the antinociceptive effects of artemisinin during inflammatory pain and interaction with the GABAergic and opioidergic systems by using a writhing response test. Methods: On the whole, 198 adult male albino mice were used in 4 experiments, including 9 groups (n = 6) each with three replicates, by intraperitoneal (i.p.) administration of artemisinin (2.5, 5, and 10 mg/kg), nal-oxone (2 mg/kg), bicuculline (2 mg/kg), saclofen (2 mg/kg), indomethacin (5 mg/kg), and ethanol (10 mL/kg). Writhing test responses were induced by i.p. injection of 10 mL/kg of 0.6% acetic acid, and the percentage of writhing inhibition was recorded.Results: Results showed significant dose dependent anti-nociceptive effects from artemisinin which, at a 10 mg/kg dose, was statistically similar to indomethacin. Neither saclofen nor naloxone had antinociceptive effects and did not antagonize antinociceptive effects of artemisinin, whereas bicuculline significantly inhibited the antinocicptive effect of artemisinin. Conclusions: It seems that antinocicptive effects of artemisinin are mediated by GABAA receptors.
Abstract
Background: Pain is a complex mechanism which involves different systems, including the opioidergic and GABAergic systems. Due to the side effects of chemical analgesic agents, attention toward natural agents have been increased. Artemisinin is an herbal compound with widespread modern and traditional therapeutic indications, which its interaction with the GABAergic system and antinoniceptive effects on neuropathic pain have shown. Therefore, this study was designed to evaluate the antinociceptive effects of artemisinin during inflammatory pain and interaction with the GABAergic and opioidergic systems by using a writhing response test. Methods: On the whole, 198 adult male albino mice were used in 4 experiments, including 9 groups (n = 6) each with three replicates, by intraperitoneal (i.p.) administration of artemisinin (2.5, 5, and 10 mg/kg), nal-oxone (2 mg/kg), bicuculline (2 mg/kg), saclofen (2 mg/kg), indomethacin (5 mg/kg), and ethanol (10 mL/kg). Writhing test responses were induced by i.p. injection of 10 mL/kg of 0.6% acetic acid, and the percentage of writhing inhibition was recorded.Results: Results showed significant dose dependent anti-nociceptive effects from artemisinin which, at a 10 mg/kg dose, was statistically similar to indomethacin. Neither saclofen nor naloxone had antinociceptive effects and did not antagonize antinociceptive effects of artemisinin, whereas bicuculline significantly inhibited the antinocicptive effect of artemisinin. Conclusions: It seems that antinocicptive effects of artemisinin are mediated by GABAA receptors.
참고문헌 (43)
- Labuz D, "Distinct roles of exogenous opioid agonists and endogenous opioid peptides in the peripheral control of neuropathy-triggered heat pain", Sci Rep, 6, pp.32799~ (2016)
- Onasanwo S A, "Antinocicep tive a nd a nti-inflammatory potentials of kolaviron : mechanisms of action", J Basic Clin Physiol Pharmacol, 27, pp.363~370 (2016)
- Staud R, "Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions", Expert Rev Neurother, 12, pp.577~585 (2012)
- Safar Zarei, "Chronic Pain and Its Determinants: A Population-based Study in Southern Iran", The Korean Journal of Pain, 25(4), pp.245~253 (2012), 대한통증학회
- Gregory NS, "An overview of animal models of pain : disease models and outcome measures", J Pain, 14, pp.1255~1269 (2013)
- Xu Q, "A brief comparison of the pathophysiology of inflammatory versus neuropathic pain", Curr Opin Anaesthesiol, 24, pp.400~407 (2011)
- LaGraize SC, "GABAA but not GABAB receptors in the rostral anterior cingulate cortex selectively modulate pain-induced escape", avoidance behavior, 2007, pp.204, 182~194
- Hasanein P, "GABAA receptors in the central nucleus of amygdala(CeA)affect on pain modulation", Brain Res, 1241, pp.36~41 (2008)
- Goudet C, "Metabotropic receptors for glutamate and GABA in pain", Brain Res Rev, 60, pp.43~56 (2009)
- Enna SJ, "The role of GABA in the mediation and perception of pain", Adv Pharmacol, 54, pp.1~27 (2006)
- Neto FL, "Distribution of GABA recep tors i n the thalamus a nd t heir i nvolvement i n nociception", Adv Pharmacol, 54, pp.29~51 (2006)
- Ying M, "Effect of artemisinin on neuropathic pain mediated by P2X4 receptor in dorsal root ganglia", Neurochem Int, 108, pp.27~33 (2017)
- Qnais EY, "Chemical composition, antinociceptive and anti-inflammatory effects of Artemisia herba-alba essential oil", J Food Agric Environ, 14, pp.20~27 (2016)
- Kaboutari J, "Prophylactic and therapeutic effects of a novel granulated formulation of Artemisia extract on broiler coccidiosis", Trop Anim Health Prod, 46, pp.43~48 (2014)
- Kaboutari Katadj J, "Wound healing effects of Artemisia sieberi extract on the second degree burn in mice skin", J Herbmed Parmacol, 5, pp.67~71 (2016)
- Favero Fde F, "Artemisia annua L.: evidence of sesquiterpene lactones’ fraction antinociceptive activity", BMC Complement Altern Med, 14, pp.266~ (2014)
- Lee S, "Artemisinin, promising lead natural product for various drug developments", Mini Rev Med Chem, 7, pp.411~422 (2007)
- Salah SM, "Two flavonoids from Artemisia herbaalba Asso with in vitro GABAA-benzodiazepine receptor activity", J Ethnopharmacol, 99, pp.145~146 (2005)
- Li J, "Artemisinins target GABAA receptor signaling and impair cell identity", Cell, 168, pp.86~100.e15 (2017)[DOI]
- Liu HK, "Artemisinin, GABA signaling and cell reprogramming : when an old drug meets modern medicine", Sci Bull, 62, pp.386~387 (2017)
- Zimmermann M, "Ethical guidelines for investigations of experimental pain in conscious animals", Pain, 16, pp.109~110 (1983)
- Zendehdel M, "Antinociceptive mechanisms of Bunium persicum essential oil in the mouse writhing test : role of opioidergic and histaminergic systems", Vet Med, 60, pp.63~70 (2015)
- de Sousa DP, "Medicinal essential oils: chemical, pharmacological and therapeutic aspects" (2012), Nova Science Publishers
- Asahi Y, "Involvement of GABAergic systems in manifestation of pharmacological activity of desipramine", Jpn J Pharmacol, 86, pp.316~322 (2001)
- Fonsêca DV, "Nerolidol exhibits antinociceptive and anti-inflammatory activity : involvement of the GABAergic system and p roinflammatory cytokines", Fundam Clin Pharmacol, 30, pp.14~22 (2016)
- Scoto GM, "Effects of intraplantar nocistatin and(±)-J 113397 injections on nociceptive behavior in a rat model of inflammation", Pharmacol Biochem Behav, 100, pp.639~644 (2012)
- Taylor F, "Nociceptin", orphanin FQ. A new opioid, a new analgesic?, 1998, pp.9, R65~R70
- Jia Y, "Nociceptin", orphanin FQ binding increases in superficial laminae of the rat spinal cord during persistent peripheral inflammation, 1998, pp.250, 21~24
- Andoh T, "Nociceptin gene expression in rat dorsal root ganglia induced by peripheral inflammation", Neuroreport, 8, pp.2793~2796 (1997)
- Merfort I, "Perspectives on sesquiterpene lactones in inflammation and cancer", Curr Drug Targets, 12, pp.1560~1573 (2011)
- Hanrahan JR, "Flavonoid modulation of GABA(A)receptors", Br J Pharmacol, 163, pp.234~245 (2011)
- Chadwick M, "Sesquiterpenoids lactones : benefits to plants and people", Int J Mol Sci, 14, pp.12780~12805 (2013)
- Dinari S, "Analgesic and anti-inflammatory effects of methanol extracts of aerial parts Artemisia aucheri in mice(Balb", c), 2016, pp.2, 33~38
- Koga K, "Chronic inflammatory pain induced GABAergic synaptic plasticity in the adult mouse anterior cingulate cortex", Mol Pain, 14 (2018)
- Woll KA, "Identification of binding sites contributing to volatile anesthetic effects on GABA type A receptors", FASEB J, 32, pp.4172~4189 (2018)
- Anseloni VC, "Inflammation-induced shift in the valence of spinal GABA-A receptor-mediated modulation of nociception in the adult rat", J Pain, 9, pp.732~738 (2008)
- Vranken JH, "Mechanisms and treatment of neuropathic pain", Cent Nerv Syst Agents Med Chem, 9, pp.71~78 (2009)
- McDonald AJ, "Immunocytochemical localization of GABABR1 receptor subunits in the basolateral amygdala", Brain Res, 1018, pp.147~158 (2004)
- Zhang XL, "Inflammatory mediator-induced modulation of GABAA currents in human sensory neurons", Neuroscience, 310, pp.401~409 (2015)
- Jang IJ, "Acute inflammation reveals GABAA receptor-mediated nociception in mouse dorsal root ganglion neurons via PGE2receptor 4 signaling", Physiol Rep, 5, pp.e13178~ (2017)
- 김민지, "Participation of central GABAA receptors in the trigeminal processing of mechanical allodynia in rats", The Korean Journal of Physiology & Pharmacology, 21(1), pp.65~74 (2017), 대한약리학회
- Malcangio M., "GABAB recep tors and pain", Neurop harmacology, 136(Part A), pp.102~105 (2018)
- Zhu Y, "Persistent inflammation increases GABA-induced depolarization of rat cutaneous dorsal root ganglion neurons in vitro", Neuroscience, 220, pp.330~340 (2012)